How to Ask Your Doctor About GLP-1 Medication
Many patients want to ask their doctor about GLP-1 medication but feel awkward, embarrassed, or unsure how to start the conversation. The reality is that your doctor discusses weight management regularly and will not judge you for bringing it up. Here are practical scripts and strategies to make the conversation productive.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Your doctor will determine whether GLP-1 medication is appropriate for your specific health situation.
Before Your Appointment: Prepare
- Know your BMI: GLP-1 medications are typically prescribed for BMI 30+ or BMI 27+ with weight-related conditions
- List your weight-related health issues: High blood pressure, type 2 diabetes, sleep apnea, joint pain, PCOS, etc.
- Document your weight history: Previous diets, exercise programs, and other weight loss attempts
- Know what you want: Are you asking about a specific medication or open to your doctor's recommendation?
Conversation Starters That Work
The Direct Approach
"I have been researching GLP-1 medications like semaglutide and tirzepatide for weight management. Given my weight history and [mention specific health condition], I would like to discuss whether I might be a good candidate."
The Health-Focused Approach
"I am concerned about how my weight is affecting my [blood pressure/blood sugar/joints/sleep]. I have tried diet and exercise, but I have not been able to achieve lasting results. I have read that GLP-1 medications can help with both weight loss and [specific condition]. Can we talk about whether that might be an option for me?"
The History-Based Approach
"I have tried [list previous approaches: calorie counting, specific diets, exercise programs] over the past [timeframe], and while I have had some success, I have not been able to maintain the weight loss. I am interested in a medical approach to weight management. What do you think about GLP-1 medications?"
If Your Doctor Says No
Not every doctor will prescribe GLP-1 medication, and that is their prerogative. If your doctor declines, ask:
- "Can you help me understand why you don't think this is appropriate for me?"
- "Would you be open to reconsidering if my weight continues to affect my health?"
- "Can you refer me to a weight management specialist or endocrinologist?"
Telehealth providers like Trimi specialize in weight management and may be more experienced with GLP-1 prescribing than general practitioners.
What Your Doctor Needs to Know
- Complete medication list (including supplements)
- Family history of thyroid cancer or MEN 2 syndrome
- History of pancreatitis or gallbladder disease
- Pregnancy plans or current pregnancy
- Previous experience with GLP-1 medications
Skip the Awkward Conversation: Use Trimi
Trimi's medical team specializes in GLP-1 therapy and evaluates your candidacy through a simple online process. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. No awkward conversations needed. Visit our treatment page to get started.
Frequently Asked Questions
Will my doctor think I am just looking for a shortcut?
Most doctors understand that obesity is a chronic medical condition, not a willpower failure. GLP-1 medications are evidence-based treatments recognized by every major medical society. A good doctor will evaluate your candidacy based on medical criteria, not judge your motivation.
Should I mention specific brand names like Ozempic or Wegovy?
It is fine to mention specific medications you have researched. However, let your doctor recommend the best option for your situation. They may suggest a different medication or a compounded version based on availability, cost, and your health profile.
What if my doctor is not knowledgeable about GLP-1 medications?
Not all primary care doctors are experienced with GLP-1 prescribing. If your doctor seems unfamiliar, ask for a referral to an endocrinologist, obesity medicine specialist, or consider a telehealth provider like Trimi that specializes in weight management.
More on Communication
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).